glp 1 shortage ending Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Novo Nordisk scores court win

Complications of type 2 diabetes

Griebeler, MD and Bartolome Burguera, MD, PhD., Should I consider metformin therapy for weight loss in patients with obesity but without diabetes

Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

42 In the STEP 1 study, participants who achieved a mean weight loss of 10.6% after 20 weeks of semaglutide were rerandomized in STEP 4 to either continue semaglutide or switch to placebo for an additional 48 weeks

Significant prior efforts across the pharmaceutical industry have failed to identify potent and efficacious small-molecule agonists of the GLP-1R ( 15, 16 )